Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics US
December 13 - 16, 2026
Marriott Marquis San Diego

Nicole Schirle Oakdale
Principal Scientist at Gilead Sciences, Inc
Speaker

Profile

Nicole Schirle Oakdale is a Principal Scientist at Gilead Sciences, Inc., where she leads a team of scientists specializing in protein engineering. With a focus on antibody lead optimization and antibody sequence optimization using structure-based rational design, Nicole's experience extends also to design of multispecific antibodies and optimization via display methodologies. Nicole has been with Gilead Sciences for seven years, contributing significantly to the advancement of therapeutic antibody development. Prior to her current role, she served as a Senior Scientist at Pfizer, where she honed her skills in protein engineering.

Agenda Sessions

  • Development of a PRAME pMHC Targeted T Cell Engager for Solid Tumor Therapy

    3:00pm